Anthera Pharmaceuticals, Inc.
ANTH
ANTH was delisted on the 27th of June, 2018.
37 hedge funds and large institutions have $6.37M invested in Anthera Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 11 closing their positions.
787% more call options, than puts
Call options by funds: $985K | Put options by funds: $111K
99% more capital invested
Capital invested by funds: $3.21M → $6.37M (+$3.16M)
18% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 11
6% more funds holding
Funds holding: 35 → 37 (+2)
57% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.35M |
| 2 |
AC
Armistice Capital
New York
|
+$1.32M |
| 3 |
6CM
683 Capital Management
New York
|
+$476K |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$361K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$60.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$196K |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$155K |
| 3 |
Millennium Management
New York
|
-$90.8K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$89.6K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$85.8K |
ANTH Hedge Fund Activity: Q4 2017 in Review
37 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Anthera Pharmaceuticals, Inc. (ANTH) for Q4 2017, worth a combined $6.37M — up 99% from $3.21M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new ANTH positions and 11 closed out — a net gain of 2 holders — while 6 added to existing stakes and 14 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.35M. The largest seller was Deutsche Bank, cutting an estimated $196K.
- 37 institutional investors held Anthera Pharmaceuticals, Inc. (ANTH) as of Q4 2017, up from 35 in Q3 2017.
- Funds reported $6.37M of Anthera Pharmaceuticals, Inc. stock for Q4 2017, up 99% quarter-over-quarter.
- 13 funds opened new Anthera Pharmaceuticals, Inc. positions in Q4 2017 and 11 closed out, a net change of +2 holders.
- The largest Anthera Pharmaceuticals, Inc. buyer in Q4 2017 was Susquehanna International Group, an estimated $1.35M added.
- The largest Anthera Pharmaceuticals, Inc. seller in Q4 2017 was Deutsche Bank, an estimated $196K sold.
Based on aggregated 13F filings for Q4 2017.